An underground economy for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on communication apps, based on new investigations.
Investigational Drug Gaining Popularity Online
The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Followers are urged to contact these accounts privately for source information, while also obtaining promotional offers.
Thriving Commerce on Messaging Platforms
Separately, a robust market exists on Telegram, where groups with numerous of members share comparison images, injection guides and assertions of next-day UK delivery. Sellers promote the substance there before redirecting customers to other platforms for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.
Healthcare Professionals Express Concerns
However, physicians and pharmacists have warned that the sale of what is still an unlicensed drug in the UK is a cause for concern and could result in individuals administering products of unknown origin.
Several experts said the demand for retatrutide could be linked to the rising cost of approved weight loss treatments such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still violate medicines, marketing, and consumer regulations, potentially leading to fines, legal action or imprisonment.
Platform Response and Content Elimination
According to TikTok, the service has removed problematic content and prohibited associated keywords and query recommendations. The organization said it was committed to maintaining the platform secure and investing in strengthening enforcement strategies.
Online Trading Operations
Research also discovered groups with up to nine thousand members selling the experimental drug using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly displays channels with numerous of users, filled with images of slimming results, glowing reviews and detailed guides for preparing or injecting at residence.
Within moments of joining one group, a vendor posted contact information, where most purchases take place. The vendor sent an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one asked about weight, medical conditions or past usage.
Product Information and Pricing
Within these communities, posts show dark colored parcels with Royal Mail labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use injectors typically priced at £160 for 20 milligrams. When asked how much time a pen should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.
Service Moderation and Safety Actions
A representative for the messaging service said it actively monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are administering substances they can’t verify. Even if the research behind retatrutide is sound, these digital products may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to current cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.
Her staff has already seen individuals injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Producer Position
A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company investigational product not yet approved … may expose patients to possibly significant medical dangers”.
